Delivery Order SPE2DB25D2207-SPE2DB25FQRRP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Progesterone 200 mg capsules in quantities of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $16,835.71 under a firm fixed-price delivery order structure, with a completion date of June 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $32,993.69. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and represents a non-set-aside award made through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) on September 12, 2025, with a contract ceiling value of $3,769.60 and an ultimate completion date of September 15, 2025. This competitively awarded, non-set-aside delivery order employs firm fixed pricing and represents a pharmaceutical supply transaction to support federal medical procurement needs. The work will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Progesterone 200 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $13,427.04. This non-set-aside delivery order is scheduled for ultimate completion on September 19, 2025, with performance conducted from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a continuation of the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $2,523.81. This is a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and represents fulfillment under AmerisourceBergen's broader pharmaceutical supply framework. The contract carries no set-aside designation, indicating it was awarded through open competition....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $3,562.06. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is set for ultimate completion by August 14, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a contract ceiling value of $7,427.51. This firm fixed-price delivery order, with an ultimate completion date of August 25, 2025, represents a competitively awarded, non-set-aside contract executed through AmerisourceBergen's existing pharmaceutical supply vehicle with the federal government. The product will be delivered...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,640.50 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Progesterone 200 mg capsules (100 count). This is a firm fixed-price delivery order with no set-aside designation, executed through competitive procedures. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and will perform this delivery from its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,473.92 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) on September 16, 2025, with an ultimate completion date of September 17, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $14,885.28. This is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB25D2207Indefinite Delivery Contract
- SPE2DB25D2207-SPE2DB25FQRRPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $1,043.85. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, and vaccines. The company's performance under this IDC demonstrates its capability to meet diverse federal medical supply requirements across multiple therapeutic domains and support Defense Health Agency operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/4/25 |